Vaccine Equity and Immunization Program Evaluation
A special issue of Vaccines (ISSN 2076-393X). This special issue belongs to the section "Human Vaccines and Public Health".
Deadline for manuscript submissions: 31 August 2024 | Viewed by 221
Special Issue Editors
Interests: evaluating and monitoring occupational and environmental health risks
Interests: epidemiology; pharmacoepidemiology; data management
Special Issue Information
Dear Colleagues,
Establishing a new vaccination program requires a commitment to equity. It is crucial to develop strategies that reach high-priority groups, such as healthcare workers or highly susceptible members of the population like older or immunocompromised individuals. It is equally important to ensure that vaccination is available to all sections of the community, including socio-economic and minority groups that have proven harder to reach in the past. Achieving this may require new engagement strategies, such as tailored community engagement plans, to communicate the vaccination's benefits and risks effectively. Both domestic and international funding should be coordinated and delivered to support these efforts. Finally, evaluating the vaccination program is imperative to demonstrate its value, ensure accountability, and learn lessons for the future.
This Special Issue welcomes scholars who are working on developing, implementing, or evaluating new immunization programs, with a focus on vaccine equity, to submit their work. The deadline for submissions is August 2024.
Dr. Mounia Hocine
Dr. Mahmoud Zureik
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- vaccine equity
- immunization program
- vaccination
- infectious disease prevention
